User menu

Handedness, insulin sensitivity and pancreatic B-cell function in Type 2 diabetes.

Bibliographic reference Hermans, Michel ; Ahn, Sylvia ; Selvais, Philippe ; Rousseau, Michel. Handedness, insulin sensitivity and pancreatic B-cell function in Type 2 diabetes.. In: Diabetic medicine : a journal of the British Diabetic Association, Vol. 26, no. 12, p. 1289-92 (2009)
Permanent URL http://hdl.handle.net/2078.1/28897
  1. Reiss, Wien Klin Wochenschr, 111, 1009 (1999)
  2. Bryden, Laterality, 10, 429 (2005)
  3. Searleman Alan, Fugagli Andrea K., Suspected autoimmune disorders and left-handedness: Evidence from individuals with diabetes, Crohn's disease and ulcerative colitis, 10.1016/0028-3932(87)90025-x
  4. Corey, Neuropsychiatry Neuropsychol Behav Neurol, 14, 144 (2001)
  5. Francks C, Maegawa S, Laurén J, Abrahams B S, Velayos-Baeza A, Medland S E, Colella S, Groszer M, McAuley E Z, Caffrey T M, Timmusk T, Pruunsild P, Koppel I, Lind P A, Matsumoto-Itaba N, Nicod J, Xiong L, Joober R, Enard W, Krinsky B, Nanba E, Richardson A J, Riley B P, Martin N G, Strittmatter S M, Möller H-J, Rujescu D, St Clair D, Muglia P, Roos J L, Fisher S E, Wade-Martins R, Rouleau G A, Stein J F, Karayiorgou M, Geschwind D H, Ragoussis J, Kendler K S, Airaksinen M S, Oshimura M, DeLisi L E, Monaco A P, LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia, 10.1038/sj.mp.4002053
  6. Chapelain Amandine S., Hogervorst Eef, Hand preferences for bimanual coordination in 29 bonobos (Pan paniscus), 10.1016/j.bbr.2008.07.012
  7. Llaurens V, Raymond M, Faurie C, Why are some people left-handed? An evolutionary perspective, 10.1098/rstb.2008.0235
  8. Grundy S. M., Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, 10.1161/circulationaha.105.169404
  9. Levy J. C., Matthews D. R., Hermans M. P., Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program, 10.2337/diacare.21.12.2191
  10. Hermans M. P., Levy J. C., Morris R. J., Turner R. C., Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes, 10.1007/s001250051215
  11. Kahn S. E., Prigeon R. L., McCulloch D. K., Boyko E. J., Bergman R. N., Schwartz M. W., Neifing J. L., Ward W. K., Beard J. C., Palmer J. P., Quantification of the Relationship Between Insulin Sensitivity and  -Cell Function in Human Subjects: Evidence for a Hyperbolic Function, 10.2337/diab.42.11.1663
  12. Bergman, Diabet Med, 13, S67 (1996)
  13. Bergman, Mt Sinai J Med, 69, 280 (2002)
  14. Guerrero-Romero F., Rodríguez-Morán M., Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus : Assessing progression to IGT and diabetes, 10.1111/j.1365-2362.2006.01728.x
  15. Utzschneider K. M., Prigeon R. L., Carr D. B., Hull R. L., Tong J., Shofer J. B., Retzlaff B. M., Knopp R. H., Kahn S. E., Impact of Differences in Fasting Glucose and Glucose Tolerance on the Hyperbolic Relationship Between Insulin Sensitivity and Insulin Responses, 10.2337/diacare.29.02.06.dc05-1963
  16. Bergman R. N., Orchestration of Glucose Homeostasis: From a Small Acorn to the California Oak, 10.2337/db07-9903
  17. Ahren B, Pacini G, Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies, 10.1530/eje.0.1500097
  18. Hermans Michel P, Diabetic macro- and microvascular disease in type 2 diabetes, 10.3132/dvdr.2007.019
  19. Munoko Thierry N., Hermans Michel P., Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes, 10.1016/j.dsx.2008.02.004
  20. Levy J., Atkinson A.B., Bell P.M., McCance D.R., Hadden D.R., Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in Type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study, 10.1002/(sici)1096-9136(199804)15:4<290::aid-dia570>3.0.co;2-m
  21. Turner Robert C., Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49), 10.1001/jama.281.21.2005